UPDATE : Monday, September 7, 2020
상단여백
Are made-in-Korea Botox products smuggled into China? by Nam Doo-hyun 2017-07-10 16:25
Breast cancer therapy Ibrance likely to get insurance benefit by Nam Doo-hyun 2017-07-07 14:26
Is it necessary to write ‘MD’ in license for herb doctors? by Nam Doo-hyun 2017-07-06 17:23
Smaller firms lead domestic stem cell market by Nam Doo-hyun 2017-07-05 13:49
Pompous start, poor showing: R&D report card of oriental medicine by Nam Doo-hyun 2017-07-05 12:00
라인
A letter to Pfizer CEO Michael Goettler by Nam Doo-hyun 2017-07-04 18:57
KISTI present ways to sharpen competitiveness of precision medicine by Nam Doo-hyun 2017-06-23 13:35
Why Roche Korea can’t unveil research results of new lung cancer therapy? by Nam Doo-hyun 2017-06-22 16:36
‘Korea needs to develop biomarkers for personalized medical services’ by Nam Doo-hyun 2017-06-22 13:24
Sanofi fuels competition in 4-strain flu vaccine market by Nam Doo-hyun 2017-06-21 11:36
라인
Kwangdong tops pharmaceuticals’ 1Q sales list of health food by Nam Doo-hyun 2017-06-20 18:47
'Bio ventures are for developing new drugs, not making cosmetics' by Nam Doo-hyun 2017-06-19 14:47
Experts call for separate organ to develop bio drugs by Nam Doo-hyun 2017-06-15 13:12
New government set to streamline healthcare R&D projects by Nam Doo-hyun 2017-06-15 11:05
Pharmaceutical industry wants to use medical big data at public organizations by Nam Doo-hyun 2017-06-14 15:46
라인
Nation needs to develop new drugs to treat senile eye diseases by Nam Doo-hyun 2017-06-12 12:28
Regulators deem Pfizer’s price for cancer therapy too high by Nam Doo-hyun 2017-06-09 17:31
‘Break global makers’ monopoly on radiotherapy device market’ by Nam Doo-hyun 2017-06-08 17:30
Biogen to enter Korean market with new therapy by Nam Doo-hyun 2017-06-07 17:40
Approvals soar for telemedicine SW, equipment by Nam Doo-hyun 2017-06-05 17:18
여백
여백
여백
Back to Top